When ‘Liver Enzymes’ Are Not Hepatic: Late-Onset Pompe Disease
Authors: Shauna Madigan, Georgina England, Wayne Rankin
Correspondence: wayne.rankin@sa.gov.au
Published online: 11 June 2026
Abstract
Elevated liver function tests are commonly attributed to hepatic disease but may reflect extrahepatic pathology. We describe the case of an 18-year-old athletic woman with a 2-year history of elevated aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatine kinase (CK) levels, initially investigated extensively for hepatic causes. Despite normal liver imaging and biopsy, ongoing abnormalities prompted metabolic evaluation, leading to the diagnosis of late-onset Pompe disease. This case highlights the diagnostic challenges of rare metabolic myopathies, the importance of recognising muscle-derived aminotransferase elevation and the need for broad diagnostic consideration when standard investigations are unrevealing.
Decolonising Indigenous Health Research Requires Redefining Sex, Sexuality and Gender
Shakara Liddelow-Hunt, James H. L. Hill, Kate Daglas, Kaiwarr Clancy, Madi Day, Alistair Ott
Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct
Ross Robertson, Andrew Downey, Daryl Williams, Bjorn Makein, Ben Dunne, Tugce Ozturk, Ying Gu, Rebecca McIntyre
Multimorbidity Clusters Among People Aged 65 Years and Over in Australia: A Nationwide Cross-Sectional Data Linkage Study
Weisi Chen, Christine Y. Lu, Sarah N. Hilmer, Alice A. Gibson, Edwin C. K. Tan
West Nile virus Kunjin subtype in rural NSW
Emily Gibson, Megan Whitley, Peter Murray, Linda Hueston, Jane Bennett, Raguharan Kathiresu, David N Durrheim
The impact of the Breast Screen NSW transition from film to digital mammography, 2002–2016: a linked population health data analysis
Rachel Farber, Nehmat Houssami, Katy J L Bell